Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578416 · ClinicalTrials.gov registry record
The Development of Stuttering in Young Children
A clinical trial of Stuttering and Stuttering, Childhood, sponsored by Michigan State University.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06578416: Recruiting study of Stuttering and Stuttering, Childhood, sponsored by Michigan State University.
NCT06578416 is a study of Stuttering and Stuttering, Childhood that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 120 participants, below the 756-participant average among 6 other Stuttering trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06578416, a study of Stuttering and Stuttering, Childhood, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this longitudinal research is to learn why some children "grow out" of stuttering, while others persist. Children who do and do not stutter aged 3-6 years are eligible to participate in our study. During the study, children's speech and language abilities will be assessed with standardized assessments, and they complete several child-friendly experiments. During these experiments, brain activity will be recorded using specialized caps while children describe pictures, children will speak in two virtual-reality scenarios, and produce speech while keeping to a beat.
Primary Outcome
Assess speech for the presence of stuttering disfluencies and calculate the severity of stuttering based on parent ratings and calculated as the percentage of disfluent syllables out of the total syllables of speech produced.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Standardized assessments of speech and language abilities
Study Locations (1)
Michigan
- Developmental Speech Lab - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-06 |
What NCT06578416 shows while recruiting
NCT06578416 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 756-participant average among 6 other Stuttering trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Stuttering appearing as the primary indexed condition, and to 1 intervention - of which Standardized assessments of speech and language abilities is the first listed.
NCT06578416 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06578416 about?
NCT06578416 is a clinical study titled "The Development of Stuttering in Young Children". The goal of this longitudinal research is to learn why some children "grow out" of stuttering, while others persist. Children who do and do not stutter aged 3-6 years are eligible to participate in our study. During the study, children's speech and language abilities will be assessed with standardiz...
What is the current status of trial NCT06578416?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-06-01. Estimated completion is 2027-06.
What conditions does trial NCT06578416 study?
This clinical trial studies the following conditions: Stuttering, Stuttering, Childhood, Stuttering, Developmental.
What interventions are being tested in trial NCT06578416?
The interventions under investigation include: Standardized assessments of speech and language abilities (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06578416?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06578416 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stuttering
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stuttering and Neuromodulation
RECRUITING · NA
-
Exploring the Nature, Assessment and Treatment of Stuttering
RECRUITING · NA
-
Network Connectivity and Temporal Processing in Adolescents Who Stutter
RECRUITING · NA
-
Speech Processing in Stuttering
COMPLETED · NA
-
Characteristics of Idiopathic Familial Speech Disorders
COMPLETED
-
Genetic Factors Related to Stuttering
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI